|
|
||||||||
J. Biol. Chem., Vol. 282, Issue 10, 7287-7298, March 9, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






¶||1
From the
Department of Pathology, ¶Department of Microbiology-Immunology, ||Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland 21201 and
Children's Memorial Research Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60614
ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser345 phosphorylation. We demonstrate here that of these three agents only Vpr requires protein phosphatase type 2A (PP2A) to activate ATR for Chk1-Ser345 phosphorylation. A requirement for PP2A by Vpr was first shown with the PP2A-specific inhibitor okadaic acid, which reduced Vpr-induced G2 arrest and Cdk1-Tyr15 phosphorylation. Using small interference RNA to down-regulate specific subunits of PP2A indicated that the catalytic
-isoform PP2A(C
) and the A regulatory
-isoform PP2A(A
) are involved in the G2 induction, and these downregulations decreased the Vpr-induced, ATR-dependent phosphorylations of Cdk1-Tyr15 and Chk1-Ser345. In contrast, the same down-regulations had no effect on hydroxyurea- or UV-activated ATR-dependent Chk1-Ser345 phosphorylation. Vpr and hydroxyurea/UV all induce ATR-mediated
H2AX-Ser139 phosphorylation and foci formation, but down-regulation of PP2A(A
) or PP2A(C
) did not decrease
H2AX-Ser139 phosphorylation by any of these agents or foci formation by Vpr. Conversely, H2AX down-regulation had little effect on PP2A(A
/C
)-mediated G2 arrest and Chk1-Ser345 phosphorylation by Vpr. The expression of vpr increases the amount and phosphorylation of Claspin, an activator of Chk1 phosphorylation. Down-regulation of either PP2A(C
) or PP2A(A
) had little effect on Claspin phosphorylation, but the amount of Claspin was reduced. Claspin may then be one of the phosphoproteins through which PP2A(A
/C
) affects Chk1 phosphorylation when ATR is activated by human immunodeficiency virus-1 Vpr.
Received for publication, August 18, 2006 , and in revised form, January 5, 2007.
* This study was supported in part by National Institute of Health Grants AI40891 and GM63080 (to R. Y. Z.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1S5.
1 To whom correspondence should be addressed: Dept. of Pathology, University of Maryland School of Medicine, 10 South Pine St., MSTF700A, Baltimore, MD 21201. Tel.: 410-706-6301; Fax: 410-706-6302; E-mail: rzhao{at}som.umaryland.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Ashwell and S. Zabludoff DNA Damage Detection and Repair Pathways--Recent Advances with Inhibitors of Checkpoint Kinases in Cancer Therapy Clin. Cancer Res., July 1, 2008; 14(13): 4032 - 4037. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huard, R. T. Elder, D. Liang, G. Li, and R. Y. Zhao Human Immunodeficiency Virus Type 1 Vpr Induces Cell Cycle G2 Arrest through Srk1/MK2-Mediated Phosphorylation of Cdc25 J. Virol., March 15, 2008; 82(6): 2904 - 2917. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. DeHart and V. Planelles Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation J. Virol., February 1, 2008; 82(3): 1066 - 1072. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |